Abiraterone 500mg Tab
Tablet is used in the treatment of cancer of the prostate gland. It may also be used to treat other conditions, as determined by the doctor. It is sometimes used with certain other medicines as part of combination chemotherapy.
Abiraterone 500 mg Tablets are a prescription hormone therapy used to treat prostate cancer that has spread (metastatic prostate cancer) in adult men. They belong to the androgen biosynthesis inhibitor class and work by lowering the production of male hormones that can fuel prostate cancer growth. They are taken together with a corticosteroid such as prednisone or prednisolone, as prescribed by the healthcare professional.
Each tablet contains 500 mg of abiraterone acetate, which the body converts into the active substance abiraterone. It is a hormone-targeted treatment rather than traditional chemotherapy.
Abiraterone is generally used alongside androgen deprivation therapy, such as treatment with an LHRH analogue or surgical removal of the testicles, depending on the clinical situation. It is not intended for use in women.
Abiraterone 500 mg Tablets may be prescribed, together with prednisone or prednisolone, to:
Treat newly diagnosed high-risk metastatic hormone-sensitive prostate cancer in adult men, in combination with androgen deprivation therapy
Treat metastatic castration-resistant prostate cancer in adult men who have no or mild symptoms after androgen deprivation therapy has stopped working, when chemotherapy is not yet clinically indicated
Treat metastatic castration-resistant prostate cancer in adult men whose disease has progressed during or after docetaxel-based chemotherapy
Approved uses may vary between countries. The appropriate treatment and dose should be determined by a healthcare professional.
Prostate cancer cells often depend on androgens, such as testosterone, to grow. Standard hormone therapy lowers androgen production in the testicles, but the adrenal glands and the tumour itself can still make these hormones.
Abiraterone blocks an enzyme called CYP17, which is needed to produce androgens in all three of these sites. When taken with castration therapy, this lowers testosterone to very low levels.
Blocking CYP17 also affects other hormones, which can cause fluid retention, high blood pressure, and low potassium. This is why a corticosteroid is taken with abiraterone.Treatment response is monitored by the healthcare team using PSA blood tests, scans, and clinical assessment as appropriate.
Take Abiraterone exactly as prescribed by your healthcare professional.
The tablets are usually taken once daily, together with prednisone or prednisolone as directed by your prescriber.
Take them on an empty stomach. They should be taken at least 2 hours after eating, and you should not eat for at least 1 hour afterwards.
Swallow the tablets whole with water.
Do not take the tablets with food. Food can greatly increase the amount of medicine absorbed.
Do not stop, change, or skip abiraterone or your corticosteroid without advice from your healthcare team.
If you miss a dose, follow the instructions provided by your healthcare professional or the patient information leaflet. Do not take extra tablets to make up for a missed dose.
Regular blood tests and monitoring of blood pressure, potassium levels, and fluid retention are usually needed during treatment.
Tell your doctor or pharmacist about your full medical history and about all medicines, supplements, and herbal products you use.
Abiraterone should not be used if you are allergic to abiraterone or any ingredient in the tablet, or if you have severe liver impairment. It must not be combined with radium-223.
Caution and closer monitoring may be needed if you have:
Liver problems, as liver function tests are checked before and during treatment
Heart disease, heart failure, or an irregular heartbeat
High blood pressure, low potassium levels, or fluid retention
Diabetes, as blood sugar may need closer monitoring
Severe kidney impairment
Reduced bone density or a history of fractures
Lactose intolerance, as some tablets contain lactose
Do not stop your corticosteroid suddenly, as this may cause adrenal problems.
Medicines and products that may interact with abiraterone include:
Strong CYP3A4 inducers, which can reduce the amount of abiraterone in the body
Medicines affected by the CYP2D6 enzyme
Medicines that may affect the heart rhythm
Spironolactone, which is generally not recommended with abiraterone
Radium-223, which must not be combined with abiraterone
This is not a full list. Check possible interactions with your doctor or pharmacist before starting or changing any medicine.
Abiraterone is not for use in women. It is contraindicated in women who are or may be pregnant, and it is not for use during breastfeeding.
Women who are or may be pregnant should not handle the tablets without protection, such as gloves. It is not known whether abiraterone passes into semen. Men are generally advised to use a condom if their partner is pregnant. If their partner could become pregnant, a condom plus another effective contraceptive method is generally advised. Speak with your doctor or pharmacist about contraception and fertility.
Like all medicines, Abiraterone can cause side effects, although not everyone experiences them.
Main side effects include:
Swelling of the legs or ankles due to fluid retention
Low potassium levels
High blood pressure
Urinary tract infection
Diarrhoea or indigestion
Increased liver enzymes
Rash
Seek prompt medical attention for severe shortness of breath, chest pain, palpitations, marked swelling or rapid weight gain. Also seek medical advice for yellowing of the skin or eyes, dark urine, severe nausea or vomiting, symptoms of a serious allergic reaction, or symptoms that may indicate very low potassium levels, such as severe muscle weakness or abnormal heart rhythm.
This is not a complete list of side effects or warnings. Please refer to the product packaging and patient information leaflet supplied with your medicine for complete information and speak with your doctor or pharmacist if you have concerns.
Store Abiraterone according to the instructions shown on the original product packaging. Storage conditions can differ between manufacturers.
Keep the tablets in their original packaging.
Keep out of reach of children.
Do not use after the expiry date shown on the packaging.
It is used, together with prednisone or prednisolone, to treat metastatic prostate cancer in adult men. Approved uses may vary by country.
The time to response varies depending on the condition and individual patient. Your treatment team will monitor your response using PSA tests, scans, and clinical assessment as appropriate.
No. Abiraterone should be taken on an empty stomach, as food can greatly increase absorption of the medicine.
Abiraterone is taken once daily at a consistent time, following the empty-stomach instructions provided with your medicine. Take it at least 2 hours after food and wait at least 1 hour before eating again.
The corticosteroid helps reduce side effects caused by hormone changes, such as high blood pressure, low potassium, and fluid retention. Do not stop it without medical advice.
Zytiga is the original brand of abiraterone acetate, and generic tablets contain the same active substance. Inactive ingredients, tablet size, packaging, and approved details may differ by manufacturer and country.
No. Do not stop or change treatment without advice from your healthcare professional, as the duration of treatment is decided by your treatment team.